Nothing Special   »   [go: up one dir, main page]

GB0808730D0 - Compositions and methods for the prevention and treatment of schistosomiasis - Google Patents

Compositions and methods for the prevention and treatment of schistosomiasis

Info

Publication number
GB0808730D0
GB0808730D0 GBGB0808730.6A GB0808730A GB0808730D0 GB 0808730 D0 GB0808730 D0 GB 0808730D0 GB 0808730 A GB0808730 A GB 0808730A GB 0808730 D0 GB0808730 D0 GB 0808730D0
Authority
GB
United Kingdom
Prior art keywords
schistosomiasis
prevention
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0808730.6A
Other versions
GB2460056A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arab Science and Tech Foundation
Original Assignee
Arab Science and Tech Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arab Science and Tech Foundation filed Critical Arab Science and Tech Foundation
Priority to GB0808730A priority Critical patent/GB2460056A/en
Publication of GB0808730D0 publication Critical patent/GB0808730D0/en
Publication of GB2460056A publication Critical patent/GB2460056A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB0808730A 2008-05-14 2008-05-14 Compositions comprising omega-6 fatty acids for use in treating schistosomiasis Withdrawn GB2460056A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0808730A GB2460056A (en) 2008-05-14 2008-05-14 Compositions comprising omega-6 fatty acids for use in treating schistosomiasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0808730A GB2460056A (en) 2008-05-14 2008-05-14 Compositions comprising omega-6 fatty acids for use in treating schistosomiasis

Publications (2)

Publication Number Publication Date
GB0808730D0 true GB0808730D0 (en) 2008-06-18
GB2460056A GB2460056A (en) 2009-11-18

Family

ID=39571314

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0808730A Withdrawn GB2460056A (en) 2008-05-14 2008-05-14 Compositions comprising omega-6 fatty acids for use in treating schistosomiasis

Country Status (1)

Country Link
GB (1) GB2460056A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017505798A (en) * 2014-02-14 2017-02-23 ディーエスエム アイピー アセッツ ビー．ブイ． Compositions and methods for preventing and / or treating schistosomiasis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321367A (en) * 1964-06-24 1967-05-23 Hoffmann La Roche Parenteral compositions containing antimony (iii) complex of 2, 3-dimercato-succinicacid
WO1993000084A1 (en) * 1991-06-24 1993-01-07 Adelaide Children's Hospital Methods and compositions for treating malaria and other diseases
GB9224809D0 (en) * 1992-11-26 1993-01-13 Scotia Holdings Plc Schizophrenia
ATE210640T1 (en) * 1994-10-13 2001-12-15 Peptide Technology Ltd MODIFIED POLYUNSATURATED FATTY ACIDS
DE19629433A1 (en) * 1996-07-22 1998-01-29 Hoechst Ag Preparation containing omega-3 fatty acids from microorganisms as a prophylactic or therapeutic agent against parasitic diseases in animals
GB9617847D0 (en) * 1996-08-27 1996-10-09 Scotia Holdings Plc Fatty acid treatment
EP2292223A1 (en) * 1998-10-15 2011-03-09 DSM IP Assets B.V. Polyunsaturated fatty acid supplements

Also Published As

Publication number Publication date
GB2460056A (en) 2009-11-18

Similar Documents

Publication Publication Date Title
HK1250393A1 (en) Methods and compositions for the detection and treatment of preeclampsia
HRP20190214T1 (en) Compositions and methods for treating purpura
EP2361089A4 (en) Compositions and methods for the treatment of altered -synuclein function
HK1207594A1 (en) Compositions and methods for the prevention and treatment of autoimmune conditions
HK1159498A1 (en) Methods and compositions for the treatment of cancer
IL209032A0 (en) Compositions and methods for treating digestive disorders
PL3208612T3 (en) Compositions and methods for the treatment of immune related diseases
IL210810A0 (en) Compositions for the treatment of pain and/or inflamtion
EP2542060A4 (en) Compositions and methods for treating and/or preventing cardiovascular disease
EP2326173A4 (en) Methods and compositions for the treatment and prevention of citrus greening disease
HK1166305A1 (en) Compositions and methods for the treatment of inflammation
EP2331123A4 (en) Compositions and methods for the treatment of hepatitis c
IL196843A0 (en) Compositions and methods for the treatment of radiation proctosigmoitis
EP2340027A4 (en) Methods and compositions for the treatment of cancer
IL210097A0 (en) Compositions and methods for treating unfluenza
EP2249789A4 (en) Compositions and methods for the treatment of xerostomia
EP2049151A4 (en) Methods and compositions for the treatment of cancer
EP2429584A4 (en) Methods and compositions for treatment
EP1996218A4 (en) Methods and compositions for the treatment of gastrointestinal disorders
IL214349A0 (en) Compositions and methods for the treatment of cancer
EP2437738A4 (en) Methods and compositions for the treatment of cancer
EP2150270A4 (en) Methods and compositions for the treatment of cancer
EP2285398A4 (en) Methods and compositions for the treatment of obesity
EP2411031A4 (en) Methods and compositions for the treatment of cancer
EP2370087A4 (en) Methods and compositions for the treatment of fluid retention disorders

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)